BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• BioCapital

  Why Some Scientists Hate NIH’s New Definition Of A Clinical Trial

  July 20, 2017

   · 

  1 min read
• Policy

  Is The FDA Biotech’s Best Friend?

  July 20, 2017

   · 

  1 min read
• 

  Business

  Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics

  July 20, 2017

   · 

  2 min read
• BioMidwest

  Better Buy: Masimo vs. Zimmer Biomet

  July 20, 2017

   · 

  1 min read
• 

  Biotech Bay

  3 Big Pharmas That Give Investors the Biggest Bang for the Buck

  July 20, 2017

   · 

  3 min read
• BioMidwest

  Nanoparticles Could Spur Better Leds, Invisibility Cloaks, University of Michigan Study Reveals

  July 20, 2017

   · 

  1 min read
• Business

  Expanding His Medical Empire Is Good For Patrick Soon-Shiong. But Is It Good For Patients?

  July 20, 2017

   · 

  1 min read
• Pharm Country

  University of Pennsylvania Researchers Engineer Macrophages To Engulf Cancer Cells In Solid Tumors

  July 20, 2017

   · 

  1 min read
• 

  Policy

  Managing Hackers and the Ongoing Healthcare Cybersecurity Crisis

  July 20, 2017

   · 

  2 min read
• 

  Drug Development

  Ironwood’s Potential Blockbuster Drug Meets Main Goals in Mid-Stage Trial

  July 20, 2017

   · 

  2 min read